{
    "clinical_study": {
        "@rank": "94252", 
        "arm_group": [
            {
                "arm_group_label": "Propofol/Dexmedetomidine", 
                "arm_group_type": "Experimental", 
                "description": "Propofol is started with dosage of 0.3 mg/kg/h, observe the patient's response, increase 0.3 mg/kg/h propofol every 10 minutes until target sedation level is obtained(Riker Sedation Agitation Score(SAS) 3-4),then 0.3-3 mg/kg/h propofol is maintained.\nAfter the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4\uff0cthe maximum dose is 1 mg/kg/h maintained\uff0cand prepare for weaning."
            }, 
            {
                "arm_group_label": "Midazolam/Dexmedetomidine", 
                "arm_group_type": "Experimental", 
                "description": "Midazolam 2 mg is slowly titrated to Riker Sedation Agitation Score(SAS) 3-4 every 10 minutes, then Midazolam 0.02-0.1 mg/kg/h is maintained.\nAfter the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4\uff0cthe maximum dose is 1 mg/kg/h maintained\uff0cand prepare for weaning."
            }
        ], 
        "brief_summary": {
            "textblock": "For the patient who passed the screen of weaning from ventilation, the traditional sedation\n      drug such as propofol and midazolam should be decreased or stopped, then it would induce the\n      stress response and agitation, such as hypertension,tachycardia etc. In order to resolve\n      that problem, the sedation should be given again. but if renewed to sedation, it would cause\n      prolonged sedation and ventilation duration.\n\n      So as to resolve above issues, after the patient passed the screen of weaning, sedation is\n      changed to Dexmedetomidine, a new sedation drug, that could wake up at any time. So our\n      study to compare the efficacy and safety of sequential sedation of propofol or midazolam and\n      dexmedetomidine in mechanical ventilated ICU patients."
        }, 
        "brief_title": "Sequential Use of Propofol/Midazolam and Dexmedetomidine for Sedation in Mechenical Ventialtion Patients in ICU.", 
        "completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Mechanical Ventilation Complication", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Written Informed Consent\n\n          2. Anticipated Ventilation and sedation duration of at least 48 hours\n\n          3. Age\u226518 years old\n\n          4. Weight is in the range of \u00b120% of standard weight.[Standard weight=\n             (Height(cm)-80)\u00d770\ufe6a for male and (Height(cm)-70)\u00d760\ufe6afor female]  -\n\n        Exclusion Criteria:\n\n          1. Extremely unstable of circulatory system, such as systolic blood pressure less than\n             90 mm Hg despite continuous infusions of vasopressors before the start of study drug\n             infusion or shock\uff1b\n\n          2. Heart rate less than 50 bpm\n\n          3. Second or third degree heart block\n\n          4. Serious central nervous system pathology(acute stroke, uncontrolled seizures,severe\n             dementia)\n\n          5. Acute hepatitis or severe liver disease (Child-Pugh class C)\n\n          6. Dialysis of all types 7\uff09History of neuromuscular disease\n\n        8) Unstable mental status and metal illness 9) Sure or suspected abuse of narcotics and\n        alcohol independence 10) Allergy to experimental drug and other contraindication 11)\n        Advanced tumor patients 12) Neuromuscular blockade other than for intubation 13) Pregnancy\n        or lactation 14) Patient that participate other trial at past 30 days  -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02122055", 
            "org_study_id": "CMATJHICU"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Propofol/Dexmedetomidine", 
                    "Midazolam/Dexmedetomidine"
                ], 
                "description": "Fentanyl 0.7-1\u03bcg/kg\uff0cprn pain assessment is done every 4 hours\uff0cmaintain Behavioral Pain Scale\uff08BPS\uff09 0-2.", 
                "intervention_name": "Fentanyl", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Propofol/Dexmedetomidine", 
                    "Midazolam/Dexmedetomidine"
                ], 
                "description": "Sedation assessment is done every 4 hours,maintain the Riker Sedation Agitation Score(SAS) 3-4.", 
                "intervention_name": "Sedation assessment", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "Propofol/Dexmedetomidine", 
                    "Midazolam/Dexmedetomidine"
                ], 
                "description": "1. Screen of weaning is done at 8:00 every morning. 2  If the patient is successful to wean,  stop the Dexmedetomidine sedation. 3. If failed to wean, the patient is ventilated again and try to wean after 24 hours, until it is successful to wean and stop sedation\uff0c", 
                "intervention_name": "Screen of weaning", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Propofol/Dexmedetomidine", 
                "description": "Propofol is started with dosage of 0.3 mg/kg/h, observe the patient's response, increase 0.3 mg/kg/h propofol every 10 minutes until target sedation level is obtained(Riker Sedation Agitation Score(SAS) 3-4),then 0.3-3 mg/kg/h propofol is maintained.", 
                "intervention_name": "Propofol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Midazolam/Dexmedetomidine", 
                "description": "Midazolam 2 mg is slowly titrated to Riker Sedation Agitation Score(SAS) 3-4 every 10 minutes, then Midazolam 0.02-0.1 mg/kg/h is maintained.", 
                "intervention_name": "Midazolam", 
                "intervention_type": "Drug", 
                "other_name": "Liyuexi"
            }, 
            {
                "arm_group_label": [
                    "Propofol/Dexmedetomidine", 
                    "Midazolam/Dexmedetomidine"
                ], 
                "description": "After the screen of the weaning is passed, change to Dexmedetomidine sedation, the dose is 0.2-0.7 mg/kg/h and continuously pumped, increase the dose 0.1-0.2 mg/kg/h every 30 minutes, titrate to Riker Sedation Agitation Score(SAS) 3-4\uff0cthe maximum dose is 1 mg/kg/h maintained\uff0cand prepare for weaning.", 
                "intervention_name": "Dexmedetomidine", 
                "intervention_type": "Drug", 
                "other_name": "Yisi"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Midazolam", 
                "Fentanyl", 
                "Propofol", 
                "Dexmedetomidine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "combined sedation", 
        "lastchanged_date": "April 22, 2014", 
        "number_of_arms": "2", 
        "official_title": "Sequential Use of Propofol/Midazolam and Dexmedetomidine for Sedation in Mechenical Ventialtion Patients in ICU, A Randomized Controlled Study.", 
        "overall_official": {
            "affiliation": "Tianjin Third Central Hospital", 
            "last_name": "Jun Li, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The time of intubation and the time of weaning from mechanical ventilation are recorded.", 
            "measure": "Ventilation duration", 
            "safety_issue": "Yes", 
            "time_frame": "From intubation to weaning from mechanical ventilation, up to 7 days."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02122055"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Using the Mini-mental State Examination(MMSE) to examine the delirium.", 
                "measure": "Delirium", 
                "safety_issue": "Yes", 
                "time_frame": "From the beginning of sedation to discharge from ICU, up to 28 days."
            }, 
            {
                "description": "blood pressure is recorded.", 
                "measure": "Blood pressure", 
                "safety_issue": "Yes", 
                "time_frame": "From the beginning to weaning of sedation, up to 7 days."
            }, 
            {
                "description": "The cost of sedation drug is calculated.", 
                "measure": "Cost of sedation drug", 
                "safety_issue": "No", 
                "time_frame": "From the admition to discharge from ICU,up to 28 days."
            }, 
            {
                "description": "Cost of narcotics is calculated.", 
                "measure": "Cost of narcotics", 
                "safety_issue": "No", 
                "time_frame": "From the admition to discharge from ICU,up to 28 days."
            }, 
            {
                "measure": "Cost of ICU stay", 
                "safety_issue": "No", 
                "time_frame": "From the beginning to weaning of sedation, up to 7 days."
            }, 
            {
                "measure": "Heart rate", 
                "safety_issue": "Yes", 
                "time_frame": "From the beginning to weaning of sedation, up to 7 days."
            }, 
            {
                "measure": "Respiration Rate", 
                "safety_issue": "Yes", 
                "time_frame": "From the beginning to weaning of sedation, up to 7 days."
            }, 
            {
                "measure": "Pulse blood oxygen saturation", 
                "safety_issue": "Yes", 
                "time_frame": "From the beginning to weaning of sedation, up to 7 days."
            }
        ], 
        "source": "Tianjin Third Central Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "Chinese Medical Association", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Tianjin Third Central Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}